Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dermata Therapeutics, Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsJun-30-23Mar-31-23Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21Mar-31-21
   10-Q10-Q10-Q10-Q10-KS-110-Q10-Q
Revenues    0.00.00.00.00.00.0
Cost of goods sold    0.00.00.00.00.00.0
Gross profit    0.00.00.00.00.00.0
Selling, general and administrative   [+]  4.74.04.43.32.82.8
Research and development    5.14.43.52.51.81.3
EBIT   [+]  -9.8-8.4-7.9-5.8-4.6-4.1
Interest expense       0.10.10.2
Pre-tax income    -9.8-8.4-7.9-5.7-4.6-4.1
Income taxes    0.00.00.00.00.00.0
            Tax rate    0.0%0.0%0.0%0.0%0.0%0.0%
Net income    -12.3-10.9-10.5-8.3-4.6-4.1
   
Basic EPS   [+]  ($4.70)($3.74)($3.20)($3.10)($2.43)($2.16)
Diluted EPS   [+]  ($4.70)($3.74)($3.20)($3.10)($2.43)($2.16)
   
Shares outstanding (basic)   [+]  2.62.93.32.71.91.9
Shares outstanding (diluted)   [+]  2.62.93.32.71.91.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy